Back
Novo Nordisk AS Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
44
NONOF
Novo Nordisk AS
Last Price:
$87.40
Seasonality Move:
4.97%
Buy
61
ASND
Ascendis Pharma AS
Last Price:
$152.46
Seasonality Move:
-0.7%
Sell
44
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.40. The Score for NONOF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Ascendis Pharma AS (ASND)
is a Buy
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $152.59. The Score for ASND is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
ASND is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.40The current trend is relatively stagnant and NONOF is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $152.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.21 | Sell |
Relative Strength Index (14 RSI): | 55.26 | Buy |
Chaikin Money Flow: | -491 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.86 - 85.92) | Buy |
Bollinger Bands (100): | (86.07 - 113.91) | Sell |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.56 | Buy |
Relative Strength Index (14 RSI): | 66.45 | Buy |
Chaikin Money Flow: | -208445 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (121.01 - 143.47) | Buy |
Bollinger Bands (100): | (124.7 - 140.4) | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.26 | Buy |
20-day SMA: | 83.91 | Buy |
50-day SMA: | 88.56 | Sell |
200-day SMA: | 117.52 | Sell |
8-day EMA: | 83.46 | Buy |
20-day EMA: | 83.86 | Buy |
50-day EMA: | 89.08 | Sell |
200-day EMA: | 106.82 | Sell |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 143.84 | Buy |
20-day SMA: | 133.1 | Buy |
50-day SMA: | 134.01 | Buy |
200-day SMA: | 132.79 | Buy |
8-day EMA: | 145.94 | Buy |
20-day EMA: | 137.82 | Buy |
50-day EMA: | 134.2 | Buy |
200-day EMA: | 131.9 | Buy |
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.38 per share, an increase this year of $3.09 per share, and an increase next year of $5.07 per share.
Novo Nordisk AS Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |